New insider activity at CME Group ( (CME) ) has taken place on February 20, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CME Group director Martin Gepsman has recently sold 300 shares of CME Group stock in a transaction valued at $91,770, signaling a notable insider move at the financial exchange operator.
Recent Updates on CME stock
CME Group shares reacted to a strong Q4 and full‑year report that showed record trading volumes, broad-based growth across asset classes, and expanding high‑margin market data and crypto businesses, supporting optimism about earnings sustainability. Analysts’ price target revisions likely reflected this robust performance and visibility, but were tempered by rising operating and cloud costs, regulatory uncertainty around prediction and securities markets, and execution risk tied to new clearing and 24/7 crypto initiatives that could pressure margins if volumes ease.
Spark’s Take on CME Stock
According to Spark, TipRanks’ AI Analyst, CME is a Outperform.
The score is driven primarily by strong financial performance (high margins and low leverage) and a constructive earnings outlook supported by record activity, pricing actions, and capital returns. Offsetting factors are a relatively high valuation and technically overbought momentum signals that raise near-term volatility/pullback risk.
To see Spark’s full report on CME stock, click here.
More about CME Group
YTD Price Performance: 11.29%
Average Trading Volume: 1,988,784
Technical Sentiment Signal: Buy
Current Market Cap: $109.1B